Literature DB >> 27146790

Post-transplant cyclophosphamide-based haplo-identical transplantation as alternative to matched sibling or unrelated donor transplantation for non-Hodgkin lymphoma: a registry study by the European society for blood and marrow transplantation.

S Dietrich1,2,3, H Finel3, C Martinez4, J Tischer5, D Blaise6, P Chevallier7, L Castagna8, N Milpied9, A Bacigalupo10, P Corradini11, M Mohty12, M Sanz13, A Hausmann14, S Montoto3,15, S Robinson3,16, A Boumendil3, A Sureda3,17, P Dreger1,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27146790     DOI： 10.1038/leu.2016.125

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  14 in total

1.  Regression modeling of competing risk using R: an in depth guide for clinicians.

Authors:  L Scrucca; A Santucci; F Aversa
Journal:  Bone Marrow Transplant       Date:  2010-01-11       Impact factor: 5.483

2.  Competing risk analysis using R: an easy guide for clinicians.

Authors:  L Scrucca; A Santucci; F Aversa
Journal:  Bone Marrow Transplant       Date:  2007-06-11       Impact factor: 5.483

3.  Unmanipulated haploidentical bone marrow transplantation and post-transplant cyclophosphamide for hematologic malignanices following a myeloablative conditioning: an update.

Authors:  A Bacigalupo; A Dominietto; A Ghiso; C Di Grazia; T Lamparelli; F Gualandi; S Bregante; M T Van Lint; S Geroldi; S Luchetti; R Grasso; S Pozzi; N Colombo; E Tedone; R Varaldo; A M Raiola
Journal:  Bone Marrow Transplant       Date:  2015-06       Impact factor: 5.483

Review 4.  HLA-haploidentical blood or marrow transplantation with high-dose, post-transplantation cyclophosphamide.

Authors:  E J Fuchs
Journal:  Bone Marrow Transplant       Date:  2015-06       Impact factor: 5.483

Review 5.  Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015.

Authors:  A Sureda; P Bader; S Cesaro; P Dreger; R F Duarte; C Dufour; J H F Falkenburg; D Farge-Bancel; A Gennery; N Kröger; F Lanza; J C Marsh; A Nagler; C Peters; A Velardi; M Mohty; A Madrigal
Journal:  Bone Marrow Transplant       Date:  2015-03-23       Impact factor: 5.483

6.  T-cell-depleted reduced-intensity transplantation followed by donor leukocyte infusions to promote graft-versus-lymphoma activity results in excellent long-term survival in patients with multiply relapsed follicular lymphoma.

Authors:  Kirsty J Thomson; Emma C Morris; Don Milligan; Anne N Parker; Ann E Hunter; Gordon Cook; Adrian J C Bloor; Fiona Clark; Majid Kazmi; David C Linch; Ronjon Chakraverty; Karl S Peggs; Stephen Mackinnon
Journal:  J Clin Oncol       Date:  2010-07-06       Impact factor: 44.544

Review 7.  Post-transplantation cyclophosphamide for tolerance induction in HLA-haploidentical bone marrow transplantation.

Authors:  Leo Luznik; Paul V O'Donnell; Ephraim J Fuchs
Journal:  Semin Oncol       Date:  2012-12       Impact factor: 4.929

8.  Rituximab after lymphoma-directed conditioning and allogeneic stem-cell transplantation for relapsed and refractory aggressive non-Hodgkin lymphoma (DSHNHL R3): an open-label, randomised, phase 2 trial.

Authors:  Bertram Glass; Justin Hasenkamp; Gerald Wulf; Peter Dreger; Michael Pfreundschuh; Martin Gramatzki; Gerda Silling; Christian Wilhelm; Matthias Zeis; Anke Görlitz; Sebastian Pfeiffer; Reinhard Hilgers; Lorenz Truemper; Norbert Schmitz
Journal:  Lancet Oncol       Date:  2014-05-11       Impact factor: 41.316

9.  Reduced-intensity transplantation for lymphomas using haploidentical related donors vs HLA-matched unrelated donors.

Authors:  Abraham S Kanate; Alberto Mussetti; Mohamed A Kharfan-Dabaja; Kwang W Ahn; Alyssa DiGilio; Amer Beitinjaneh; Saurabh Chhabra; Timothy S Fenske; Cesar Freytes; Robert Peter Gale; Siddhartha Ganguly; Mark Hertzberg; Evgeny Klyuchnikov; Hillard M Lazarus; Richard Olsson; Miguel-Angel Perales; Andrew Rezvani; Marcie Riches; Ayman Saad; Shimon Slavin; Sonali M Smith; Anna Sureda; Jean Yared; Stefan Ciurea; Philippe Armand; Rachel Salit; Javier Bolaños-Meade; Mehdi Hamadani
Journal:  Blood       Date:  2015-12-15       Impact factor: 22.113

10.  Unmanipulated haploidentical BMT following non-myeloablative conditioning and post-transplantation CY for advanced Hodgkin's lymphoma.

Authors:  A Raiola; A Dominietto; R Varaldo; A Ghiso; F Galaverna; S Bramanti; E Todisco; B Sarina; L Giordano; A Ibatici; A Santoro; M Clavio; A Bacigalupo; L Castagna
Journal:  Bone Marrow Transplant       Date:  2013-11-04       Impact factor: 5.483
View more
  11 in total

1.  Diffuse large B-cell lymphoma: the challenge of relapse after an autologous stem cell transplant.

Authors:  S P Robinson
Journal:  Bone Marrow Transplant       Date:  2016-11-21       Impact factor: 5.483

2.  HLA-haploidentical vs matched-sibling hematopoietic cell transplantation: a systematic review and meta-analysis.

Authors:  Mohamad A Meybodi; Wenhao Cao; Leo Luznik; Asad Bashey; Xu Zhang; Rizwan Romee; Wael Saber; Mehdi Hamadani; Daniel J Weisdorf; Haitao Chu; Armin Rashidi
Journal:  Blood Adv       Date:  2019-09-10

3.  Allogeneic Transplantation for Follicular Lymphoma: Does One Size Fit All?

Authors:  Mehdi Hamadani; Mary M Horowitz
Journal:  J Oncol Pract       Date:  2017-12       Impact factor: 3.840

4.  Outcomes of Medicare-age eligible NHL patients receiving RIC allogeneic transplantation: a CIBMTR analysis.

Authors:  Nirav N Shah; Kwang Woo Ahn; Carlos Litovich; Timothy S Fenske; Sairah Ahmed; Minoo Battiwalla; Nelli Bejanyan; Parastoo B Dahi; Javier Bolaños-Meade; Andy I Chen; Stefan O Ciurea; Veronika Bachanova; Zachariah DeFilipp; Narendranath Epperla; Nosha Farhadfar; Alex F Herrera; Bradley M Haverkos; Leona Holmberg; Nasheed M Hossain; Mohamed A Kharfan-Dabaja; Vaishalee P Kenkre; Hillard M Lazarus; Hemant S Murthy; Taiga Nishihori; Andrew R Rezvani; Anita D'Souza; Bipin N Savani; Matthew L Ulrickson; Edmund K Waller; Anna Sureda; Sonali M Smith; Mehdi Hamadani
Journal:  Blood Adv       Date:  2018-04-24

5.  PTCy-based haploidentical vs matched related or unrelated donor reduced-intensity conditioning transplant for DLBCL.

Authors:  Peter Dreger; Anna Sureda; Kwang Woo Ahn; Mary Eapen; Carlos Litovich; Herve Finel; Ariane Boumendil; Ajay Gopal; Alex F Herrera; Christoph Schmid; José Luis Diez-Martin; Ephraim Fuchs; Javier Bolaños-Meade; Mahasweta Gooptu; Monzr M Al Malki; Luca Castagna; Stefan O Ciurea; Alida Dominietto; Didier Blaise; Fabio Ciceri; Johanna Tischer; Paolo Corradini; Silvia Montoto; Stephen Robinson; Zafer Gülbas; Mehdi Hamadani
Journal:  Blood Adv       Date:  2019-02-12

Review 6.  Haploidentical stem cell transplantation for patients with lymphoma: a position statement from the Lymphoma Working Party-European Society for Blood and Marrow Transplantation.

Authors:  Sascha Dietrich; Peter Dreger; Olivier Hermine; Chara Kyriakou; Silvia Montoto; Steve Robinson; Norbert Schmitz; Harry C Schouten; Anna Sureda; Alina Tanase
Journal:  Bone Marrow Transplant       Date:  2019-05-31       Impact factor: 5.483

7.  Nonmyeloablative Alternative Donor Transplantation for Hodgkin and Non-Hodgkin Lymphoma: From the LWP-EBMT, Eurocord, and CIBMTR.

Authors:  Giancarlo Fatobene; Vanderson Rocha; Andrew St Martin; Mehdi Hamadani; Stephen Robinson; Asad Bashey; Ariane Boumendil; Claudio Brunstein; Luca Castagna; Alida Dominietto; Hervé Finel; Yves Chalandon; Chantal Kenzey; Mohamed Kharfan-Dabaja; Hélène Labussière-Wallet; Jose M Moraleda; Rocco Pastano; Miguel-Angel Perales; Hanadi Rafii El Ayoubi; Annalisa Ruggeri; Anna Sureda; Fernanda Volt; Ibrahim Yakoub-Agha; Mei-Jie Zhang; Eliane Gluckman; Silvia Montoto; Mary Eapen
Journal:  J Clin Oncol       Date:  2020-02-07       Impact factor: 50.717

8.  Similar outcomes after haploidentical transplantation with post-transplant cyclophosphamide versus HLA-matched transplantation: a meta-analysis of case-control studies.

Authors:  Zhenyang Gu; Li Wang; Lei Yuan; Wenrong Huang; Meng Li; Lixun Guan; Qingyi Wang; Zhe Gao; Shasha Zhao; Lan Luo; Feiyan Wang; Nan Yang; Daihong Liu; Jon C Aster; Chunji Gao
Journal:  Oncotarget       Date:  2017-06-29

9.  Graft Cryopreservation Does Not Impact Overall Survival after Allogeneic Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease Prophylaxis.

Authors:  Mehdi Hamadani; Mei-Jie Zhang; Xiao-Ying Tang; Mingwei Fei; Claudio Brunstein; Saurabh Chhabra; Anita D'Souza; Filippo Milano; Rachel Phelan; Wael Saber; Bronwen E Shaw; Daniel Weisdorf; Steven M Devine; Mary M Horowitz
Journal:  Biol Blood Marrow Transplant       Date:  2020-04-10       Impact factor: 5.742

Review 10.  Haploidentical Stem Cell Transplantation in Lymphomas-Expectations and Pitfalls.

Authors:  Jacopo Mariotti; Stefania Bramanti; Armando Santoro; Luca Castagna
Journal:  J Clin Med       Date:  2020-11-07       Impact factor: 4.241
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.